PTPRC and prostate carcinoma: To probe whether the recovery of CTC could be improved two blood samples of a prostate cancer patient were processed with the procedure, one with the standard approach and one in which the CD45 depleted sample was permeabilized and fixed to allow for Cytokeratin staining.